A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma

Cisplatin-based concurrent chemoradiotherapy for patients with unresectable, locally advanced esophageal squamous cell carcinoma (ESCC) is associated with significant toxicities that are often intolerable. Prognosis for this subgroup of patients remains poor, and new therapeutic approaches are urgen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Zhao, Chuanhua, Lin, Li, Liu, Jianzhi, Liu, Rongrui, Chen, Yuling, Ge, Feijiao, Jia, Ru, Jin, Yang, Wang, Yan, Xu, Jianming
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5302991/
https://ncbi.nlm.nih.gov/pubmed/28087951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9809
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares